PHARMACENTRIC SOLUTIONS LIMITED
Significant control: Gregor John Mclennan Anderson (25–50%), Pauline Williams (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Pharmacentric Solutions Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Pharmacentric Solutions Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PHARMACENTRIC SOLUTIONS LIMITED is an active private limited company (company number 10948509) incorporated on 6 September 2017, registered in Hitchin. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 September 2025, showing net assets of £157k and cash of £147k, with 0 employees on average. Net assets fell 2% on the prior period (£160k).
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Mr Gregor John Mclennan Anderson
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Pauline Williams
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 6 September 20179 yrs ago
- Next accounts due
- 30 June 2027in 245 days
- Confirmation statement due
- 20 September 2027in 327 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £157k | £147k | — | £7,461 | — | — | 0 |
| 30 September 2024 | £160k | £143k | £172 | £4,222 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £157,377 at 30 September 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 19.76
- Cash at bank of £50,000 or moreCash £147,422
- Incorporated five or more years agoIncorporated 6 September 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 327 days
- Next accounts duein 245 days
- Accounts period endNet assets £157k · small accounts
- Accounts period endNet assets £160k · small accounts
- Incorporated
Similar companies in Hertfordshire
- SWANBIO THERAPEUTICS LIMITEDStevenage · inc. Sept 2017
- PHYTOFORM LABS LTDHarpenden · inc. Aug 2017
- PAM BROWN CONSULTING LTDSt Albans · inc. Oct 2017
- DIOSYNVAX LTD.Hertford · inc. Jul 2017
- THE FOUNDRY (CAMBRIDGE) LIMITEDHatfield · inc. Jun 2017
- VARANOU JENKINS SCIENTIFIC LTDHenlow · inc. Mar 2017
All companies incorporated on 6 September 2017 · in Sept 2017.
Reminders for PHARMACENTRIC SOLUTIONS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.